NASDAQ: XERSXeris Biopharma Holdings Inc Stock Ownership - Who owns Xeris Biopharma Holdings?
Insider buying vs selling
Have Xeris Biopharma Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kevin McCulloch | President and Chief Operating Officer | 2025-04-02 | 733 | $5.15 | $3.77kSell |
| Beth Hecht | Chief Legal Officer and Corporate Secretary | 2025-03-20 | 40,000 | $5.43 | $217.24kSell |
| Beth Hecht | Chief Legal Officer and Corporate Secretary | 2025-01-31 | 98,375 | $3.56 | $350.22kSell |
| Kenneth Erland Johnson | Senior Vice President Global Development and Medical Affairs | 2025-01-31 | 25,842 | $3.56 | $92.00kSell |
| Kenneth Erland Johnson | Senior Vice President Global Development and Medical Affairs | 2025-01-31 | 15,476 | $3.56 | $55.09kSell |
| John Patrick Shannon Jr. | Chief Executive Officer and Director | 2025-01-31 | 110,750 | $3.56 | $394.27kSell |
| Beth Hecht | Chief Legal Officer and Corporate Secretary | 2025-01-31 | 45,909 | $3.56 | $163.44kSell |
| Kevin McCulloch | President and Chief Operating Officer | 2025-01-31 | 29,300 | $3.56 | $104.31kSell |
| Kevin McCulloch | President and Chief Operating Officer | 2025-01-31 | 48,834 | $3.56 | $173.85kSell |
| Steven Pieper | Chief Financial Officer | 2025-01-31 | 110,750 | $3.56 | $394.27kSell |
XERS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when XERS insiders and whales buy or sell their stock.
XERS Shareholders
What type of owners hold Xeris Biopharma Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 6.74% | 10,794,601 | $47.71M | Institution |
| Vanguard Group Inc | 5.06% | 8,109,644 | $35.84M | Institution |
| Redmile Group LLC | 3.38% | 5,413,284 | $23.93M | Insider |
| Morgan Stanley | 2.68% | 4,288,281 | $18.95M | Institution |
| Paul R. Edick | 2.42% | 3,868,354 | $17.10M | Insider |
| Geode Capital Management LLC | 2.13% | 3,405,826 | $15.05M | Institution |
| State Street Corp | 2.08% | 3,325,255 | $14.70M | Institution |
| D E Shaw Co Inc | 1.91% | 3,052,372 | $13.49M | Institution |
| Goldman Sachs Group Inc | 1.74% | 2,790,014 | $12.33M | Institution |
| John Patrick Shannon Jr. | 1.68% | 2,687,118 | $11.88M | Insider |
XERS vs Biotech Stocks
Xeris Biopharma Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.